Risk Intelligence
Take rate compression due to AI automation
View Risks →Medi Assist delivered a strong FY26 with operating revenue of ₹904.8 crore (+25.1% YoY) and EBITDA of ₹174.6 crore (19.3% margin).
✓ Verified against BSE filing
Medi Assist delivered a strong FY26 with operating revenue of ₹904.8 crore (+25.1% YoY) and EBITDA of ₹174.6 crore (19.3% margin). Growth was driven by group premiums (+25.6% YoY), technology revenue (+91.9% YoY), and government business (+42.6% YoY). The company became debt-free and net cash positive. Management guided for continued strong growth in technology and international segments, with Paramount integration on track to complete by Q2 FY27. Key risk: potential compression of take rates as AI automation becomes more widespread, though management argues value-added services and outcome-based pricing will protect margins.
Take rate compression due to AI automation
View Risks →Full transcript text is available on this route.
Read Transcript →Group premiums grew 25.6% to ₹23,000+ crore; retail premiums grew 4.2% to ₹2,818 crore.
Slightly lower than historical 94%+ due to deliberate quality-of-revenue decisions and operational changes.
Group segment market share reached 33.7% (+340bps YoY); retail TPA model share was 5%.
AI fraud detection platform prevented over ₹540 crore in health insurance fraud in FY26.
Over 50% of Paramount claims volume already migrated to Matrix; full migration and synergy realization expected within 1-2 quarters.
Analyst raised concern that increasing automation could reduce industry take rates from ~3.5% to 2.5% over time, pressuring revenue per premium.
View Risks →